Երկիր: Ավստրալիա
Լեզու: անգլերեն
Աղբյուրը: APVMA (Australian Pesticides and Veterinary Medicines Authority)
PIMOBENDAN
Boehringer Ingelheim Animal Health Australia Pty. Ltd.
pimobendan(5mg/Tb)
ORAL BOLUS, CHEWABLE
PIMOBENDAN PYRIDAZINONE Active 5.0 mg/Tb
50tablets
VM - Veterinary Medicine
DOG | BITCH | CASTRATE | PUPPY
CARDIOVASCULAR SYSTEM
CONGESTIVE HEART FAILURE | DILATED CARDIOMYOPATHY | MITRAL AND/OR TRICUSPID REGUR | VALVULAR INSUFFICIENCY
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [CONGESTIVE HEART FAILURE, PRECLINICAL MYXOMATOUS MITRAL VALVE DISEASE]; DOG - LARGE: [PRECLINICAL DCM, PRECLINICAL MYXOMATOUS MITRAL VALVE DISEASE]; For the treatment of canine congestive heart failure (CHF) originating from dilated cardiomyopathy (DCM) or valvular insufficiency (mitral and/or tricuspid regurgitation).Should NOT be used in cases of hypertrophic cardiomyopathies or clinical conditions where an augmentation of cardiac output is NOT recommended for functional or anatomical reasons (e.g. aortic stenosis). See Precautions on label also.
Registered
2023-07-01
For Official Use Only E-LABEL APPLICATION (DRAFT) COMPANY NAME: BOEHRINGER INGELHEIM PTY LIMITED, VETMEDICA DIVISION PRODUCT NAME: VETMEDIN 5 MG CHEWABLE TABLETS FOR DOGS ELABEL APPLICATION NO: DC14-24070078E12 APVMA APPROVAL NO: 60798/101024 PRODUCT NO: 60798 VERSION NO: 6.0 APPLICATION STARTED: 2014-Sep-15 16:05:01 VERSION CREATED: 2015-Aug-05 12:56:48 STARTED BY: Lisa Wade PRINTED: 2015-Aug-05 15:31:31 LABEL NAME: VETMEDIN 5 MG CHEWABLE TABLETS FOR DOGS SIGNAL HEADINGS: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY CONSTITUENT STATEMENTS: Each tablet contains 5 mg pimobendan. CLAIMS: Vetmedin® Chewable Tablets are indicated for: The treatment of canine congestive heart failure (CHF) originating from dilated cardiomyopathy (DCM) or valvular insufficiency (mitral and/or tricuspid regurgitation). The treatment of preclinical DCM in large breed dogs. When used in cases of preclinical DCM in large breed dogs, pimobendan significantly prolonged the time to the onset of CHF or sudden death, and also resulted in prolongation of the time to death due to all causes. Doberman Pinscher dogs with preclinical DCM treated with pimobendan also demonstrated a significant reduction in Left Ventricular Internal Diameter in both systole and diastole (LVIDs/d) in response to therapy. NET CONTENTS: White high density polyethylene screw-necked bottle with polypropylene child-resistant closure containing 50 beef flavoured palatable tablets . DIRECTIONS FOR USE: RESTRAINTS: CONTRAINDICATIONS: This product is contraindicated for use in cases of hypertrophic cardiomyopathies or clinical conditions where an augmentation of cardiac output is not recommended for functional or anatomical reasons (e.g. aortic stenosis). RLP APPROVED For Official Use Only PRECAUTIONS: Vetmedin® Chewable Tablets should only be administered to pregnant and lactating bitches if the expected therapeutic benefits overweigh the potential risk. Studies into the effect of pimobendan on the reproductive function of male dogs have Կարդացեք ամբողջական փաստաթուղթը
CS: 1.9.46 Page: 1 MATERIAL SAFETY DATA SHEET 4 of Infosafe No™ LQ1I5 September 2012 ISSUED by BOEHRING Issue Date : VETMEDIN® CHEWABLE TABLETS FOR DOGS Product Name : Not classified as hazardous 1. IDENTIFICATION OF THE MATERIAL AND SUPPLIER VETMEDIN® CHEWABLE TABLETS FOR DOGS PRODUCT NAME Boehringer Ingelheim Pty. Limited COMPANY NAME 78 Waterloo Rd North Ryde NSW 2113 Australia ADDRESS 1800 038 037 EMERGENCY TEL. Tel: 1800 038 037 Fax: +61 2 8875 8715 TELEPHONE/FAX NUMBER animalhealth.au@boehringer-ingelheim.com EMAIL Vetmedin® chewable tablets are indicated for the treatment of canine congestive heart failure originating from dilated cardiomyopathy or valvular insufficiency (mitral and/or tricuspid regurgitation). RECOMMENDED USE 2. HAZARDS IDENTIFICATION Not classified as hazardous NON-HAZARDOUS SUBSTANCE. NON-DANGEROUS GOODS. Not Classified as Hazardous according to criteria of National Occupational Health & Safety Commission, Australia (NOHSC). Not Classified as Dangerous Goods according to the Australian Code for the Transport of Dangerous Goods by Road and Rail. (7th edition) HAZARD CLASSIFICATION 3. COMPOSITION/INFORMATION ON INGREDIENTS Pimobendan, a benzimidazole-pyridazinone derivative, is a non-sympathomimentic, non-glycoside inotropic substance with potent vasodilatative properties. 1.25 mg beef flavoured palatable chewable tablet contains 1.25 mg pimobendan 5 mg beef flavoured palatable chewable tablet contains 5 mg pimobendan 2.5 mg beef flavoured palatable chewable tablet contains 2.5 mg pimobendan INFORMATION ON COMPOSITION NAME RISK PHRASE CAS PROPORTION HAZARD SYMBOL INGREDIENTS Pimobendan (3(2H)-Pyridazinone, 4,5-dihydro-6-[2- (4-methoxyphenyl)-1H-be nzimidazol-5-yl]-5-meth yl-) 74150-27-9 <=2 % Ingredients determined not to be hazardous - Balance 4. FIRST AID MEASURES No special precautions required. However, if inhaled, remove affected person from contaminated area. Keep at rest until recovered. If symptoms persist seek medical attention. INHALATION Do not induce vomiting. Wash out mo Կարդացեք ամբողջական փաստաթուղթը